Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other solid neoplasm 1Gynecologic 1

Conditions

Lung Neoplasms 48Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 11Prostatic Neoplasms 7Gastrointestinal Neoplasms 5Colorectal Neoplasms 4cyclopia sequence 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Pleural Effusion, Malignant 2Pain 2Mesothelioma 2Melanoma 2Lung Diseases 2Lung Cancer Screening 2Colonic Neoplasms 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Tobacco Use Cessation 1Thyroid Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Smoking Cessation 1Smoke Inhalation Injury 1Small Cell Lung Carcinoma 1Sleepiness 1Sarcoma 1Respiratory Aspiration 1Radiation Pneumonitis 1Pseudomyxoma Peritonei 1

Interventions

irinotecan sucrosofate 1Surveys and Questionnaires 1Referral and Consultation 1Oxaliplatin 1Observation 1Leucovorin 1Ifosfamide 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Surveys and Questionnaires × Thoracic × Clear all
NCT01126346 2018-07-03

HOPE

Wake Forest University Health Sciences

Phase NA Completed
10 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Appendiceal Neoplasms, Colonic Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡